Mandate

Vinge advises Eleda in connection with the acquisition of Gatu och Väg Väst AB

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Gatu och Väg Väst AB (“GVV”).

GVV is based in Gunnilse and conducts construction and contracting operations in the south western Sweden, focusing on concrete maintenance work on, inter alia, bridges, power plants and port facilities. GVV has approximately 70 employees and yearly sales of around SEK 240 million. The company’s management team will continue in their respective operational management roles and become shareholders of the Eleda group.

Closing of the transaction is subject to applicable competition law approvals and other customary closing conditions.

Vinge’s team consisted primarily of partner Christina Kokko and associates Michaela Cronemyr and Carl Fredrik Wachtmeister (M&A), Isak Willborg (Agreements), Ebba Svenburg (Employment), Frida Ställborn (Real Property & Environment), Johan Wahlbom and Joel Kokko (Competition), Tove Lövgren Frisk (Compliance) and Carl Bruneheim (VDR-specialist).

 

Related

Vinge advises Stendörren in connection with issuance of green capital securities

Vinge has advised Stendörren Fastigheter AB in connection with its issuance of green capital securities in an amount of SEK 400 million (within a framework of SEK 800 million).
May 07, 2026

Vinge represents Cinven in connection with the acquisition of Ongoing Warehouse

Vinge has represented the international private equity firm Cinven in connection with its acquisition of Ongoing Warehouse.
May 06, 2026

Vinge advises Fazer in connection with its acquisition of Aroma

Fazer has entered into an agreement to acquire Konfektyrfabriken Aroma AB, a Swedish confectionery manufacturer known for its classic candy products such as Geléhallon, Hallonbåtar, Röda Hjärtan and Gräddkola. The acquisition strengthens Fazer's position in the Swedish confectionery market, particularly within pick & mix, packed candy, and seasonal products. The acquisition is subject to customary regulatory approvals.
May 06, 2026